top of page

Effect of Methylenedioxymethamphetamine (MDMA) (Serotonin Release) on Fear Extinction

About the study

NCT Trial Number

NCT03527316

The drug being studied

MDMA

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

University Hospital, Basel, Switzerland

noun_date_3237048.png

Trial Start Date

Oct-18

noun_capsule_138144.png

About the participants

Age seeking

18 Years to 50 Years

gender

Male

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Healthy

noun_square_138133.png

Accepts healthy volunteers?

Yes

A study to evaluate the role of serotonin release, induced by MDMA, to reduce the fear response.

Eyes Graffiti

Locations

Switzerland
Clinical Pharmacology & Toxicology, University Hospital Basel
Basel, Switzerland, 4056

Contact: Matthias E Liechti, Prof.Dr.med.
+41 61 265 88 68 ext +41
matthias.liechti@usb.ch

Contact: Patrick Vizeli, MSc
+41 61 556 54 22 ext +41
patrick.vizeli@usb.ch

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page